Posted on

cbd results

Over the past several years, FDA has issued several warning letters to firms that market unapproved new drugs that allegedly contain cannabidiol (CBD). As part of these actions, FDA has tested the chemical content of cannabinoid compounds in some of the products, and many were found to not contain the levels of CBD they claimed to contain. It is important to note that these products are not approved by FDA for the diagnosis, cure, mitigation, treatment, or prevention of any disease. Consumers should beware purchasing and using any such products.

“Potency testing is important as consumers want to know about the active ingredients – and how much they will be taking per serving,” Titus said. “Often, children with epilepsy will be “dosed” or served according to their body weight and will require a specific amount of product (likely CBD) to control seizure episodes.”

“Third-party lab testing is extremely important for the industry as wholesalers and consumers need to know the exact ingredients that make up a final, finished product that will be delivered to the market,” Titus explained. “The purity of the product – that there are no residual toxins, pesticides, heavy metals or other contaminants – makes for a consumer-safe product. Many children take non-psychoactive forms of cannabis and certainly doctors and parents want to know that the product is lab-tested and assured safe for the child.”

An analysis from Leafreport found that only 25% of CBD products are tested for purity.

CBD Potency Testing Also Important

The analysis from Leafreport also listed the 10 most transparent and accurate CBD brands, based on test results for potency and purity. Stuart Tomc, the senior vice president for business development for CV Sciences, says that his company’s PlusCBD brand made the list because they are tested multiple times.

The CBD industry as a whole is doing a better job of reporting testing results for the potency of the cannabinoid in their products. Leafreport’s analysis found that only 4% of brands listed test results for 10% or fewer of their products. Still, only 42% of brands test at least 90% of their products for potency and share their third-party lab results with consumers. The review also found that the potency determined by independent lab testing frequently did not match the strength advertised on product labels, with 84% of potency-tested products not testing within 10% of the advertised amount of CBD.

“At CV Sciences, we do not cut corners. Our PlusCBD products undergo rigorous in-house testing for safety, quality, and consistency throughout the manufacturing process,” Tomc writes in an email. “In addition, all PlusCBD products undergo third-party testing to double verify what is in the bottle matches what is on the label, and we publish certificates of analysis showing results of in-house and third-party testing on our website.”

In a report published last month, online CBD educational resource Leafreport reviewed the lab analysis data for 2,946 cannabidiol (CBD) products from 136 brands to determine how many companies test their products for purity and potency. The investigation also looked for discrepancies between the amount of CBD advertised on product packaging and the actual potency revealed by lab testing. With more and more consumers trying CBD to treat health conditions including anxiety, inflammation and pain, transparency in labeling can help them achieve the results they desire.

CBD has been touted for a wide variety of health issues, but the strongest scientific evidence is for its effectiveness in treating some of the cruelest childhood epilepsy syndromes, such as Dravet syndrome and Lennox-Gastaut syndrome (LGS), which typically don’t respond to antiseizure medications. In numerous studies, CBD was able to reduce the number of seizures, and, in some cases, it was able to stop them altogether. Videos of the effects of CBD on these children and their seizures are readily available on the Internet for viewing, and they are quite striking. Recently the FDA approved the first ever cannabis-derived medicine for these conditions, Epidiolex, which contains CBD.

Some CBD manufacturers have come under government scrutiny for wild, indefensible claims, such that CBD is a cure-all for cancer, which it is not. We need more research but CBD may be prove to be an option for managing anxiety, insomnia, and chronic pain. Without sufficient high-quality evidence in human studies we can’t pinpoint effective doses, and because CBD is currently is mostly available as an unregulated supplement, it’s difficult to know exactly what you are getting. If you decide to try CBD, talk with your doctor — if for no other reason than to make sure it won’t affect other medications you are taking.

The evidence for cannabidiol health benefits

Cannabidiol (CBD) has been recently covered in the media, and you may have even seen it as an add-in booster to your post-workout smoothie or morning coffee. What exactly is CBD? Why is it suddenly so popular?

CBD is commonly used to address anxiety, and for patients who suffer through the misery of insomnia, studies suggest that CBD may help with both falling asleep and staying asleep.

CBD may offer an option for treating different types of chronic pain. A study from the European Journal of Pain showed, using an animal model, CBD applied on the skin could help lower pain and inflammation due to arthritis. Another study demonstrated the mechanism by which CBD inhibits inflammatory and neuropathic pain, two of the most difficult types of chronic pain to treat. More study in humans is needed in this area to substantiate the claims of CBD proponents about pain control.